American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
    Research Letter

    Rosenbaum, C. A.; Özbek, U.; Sanchez, L.; Lagdameo, J.; Abrahams, A.; Hassoun, H.; Lahoud, O.; Niesvizky, R.; Landau, H. J.; Osman, K.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
    Journal Article

    Los-de Vries, G. T.; Stevens, W. B. C.; van Dijk, E.; Langois-Jacques, C.; Clear, A. J.; Stathi, P.; Roemer, M. G. M.; Mendeville, M.; Hijmering, N. J.; Sander, B.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
    Journal Article

    Hasan, A. N.; Doubrovina, E.; Sottile, R.; Prockop, S.; Klatt, M. G.; Heller, G.; Selvakumar, A.; Barnett, L.; Hsu, K. C.; O’Reilly, R. J.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
    Research Letter

    Zhang, J.; Wang, T.; Shetty, K.; Alkan, S.; Xu, S.; Gong, Q.; Liu, X.; Li, Y.; Hu, Z.; Huang, W.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
    Journal Article

    Qualls, D.; Lam, H. Y.; Whiting, K.; Kumar, A.; Matasar, M.; Owens, C.; Nichols, C.; Espeleta, J. A.; Qiu, A.; Subzwari, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma
    Research Letter

    Soumerai, J. D.; Rosenthal, A.; Harkins, S.; Duffy, J.; Mecca, C.; Wang, Y.; Grewal, R. K.; El-Jawahri, A. R.; Liu, H.; Menard, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: A meta-analysis
    Journal Article

    Shafagati, N.; Koh, M. J.; Boussi, L.; Park, H. J.; Stuver, R.; Bain, P.; Foss, F. M.; Shen, C.; Jain, S.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
    Research Letter

    Jaeger, U.; Tam, C. S.; Borchmann, P.; McGuirk, J. P.; Johansen, M.; Waller, E. K.; Jaglowski, S.; Andreadis, C.; Foley, S. R.; Westin, J. R.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
    Journal Article

    Tanaka, A.; Nakano, T. A.; Nomura, M.; Yamazaki, H.; Bewersdorf, J. P.; Mulet-Lazaro, R.; Hogg, S.; Liu, B.; Penson, A.; Yokoyama, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Revision of RUNX1 variant curation rules
    Editorial

    Feurstein, S.; Luo, X.; Shah, M.; Walker, T.; Mehta, N.; Wu, D.; Godley, L. A.; Feurstein, S.; on behalf of the Myeloid Malignancy Variant Curation Expert Panel
    Blood Advances (2022)

    Fulltext@MSK | Save